Publications by authors named "Claudio Magistris"

Claim this Profile
G
Genomics Define Malignant Transformation in Myeloma Precursor Conditions.
Francesco Maura, P Leif Bergsagel, Bachisio Ziccheddu, Shaji Kumar, Kylee Maclachlan, Claudio de Magistris

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab-, Elotuzumab-, and Carfilzomib-Based Triplet Regimens: A Multicenter Real-World Analysis of 635 Patients.
Fortunato Morabito, Enrica Antonia Martino, Monica Galli, Massimo Offidani, Renato Zambello, Claudio De Magistris

Eur J Haematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes.
Marta Lionetti, Margherita Scopetti, Antonio Matera, Akihiro Maeda, Alessio Marella, Claudio De Magistris

Blood· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma.
Matteo Claudio Da Vià, Francesca Lazzaroni, Antonio Matera, Alessio Marella, Akihiro Maeda, Claudio De Magistris

Blood· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0).
Floris Chabrun, Daniel Schwartz, Susanna Gentile, Elias Mai, Tulika Gupta, Claudio de Magistris

Res Sq· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials.
Enrica Antonia Martino, Daniele Derudas, Elena Rossi, Sofia Terlizzi, Giovanni Reddiconto, Claudio De Magistris

Haematologica· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab-Refractory Multiple Myeloma Patients: A Multicenter Real-World Study.
Enrica Antonia Martino, Daniele Derudas, Elena Rossi, Paola Stefanoni, Silvia Mangiacavalli, Claudio De Magistris

Hematol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of isatuximab-pomalidomide-dexamethasone elotuzumab-pomalidomide-dexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data.
Enrica Antonia Martino, Annalisa Pitino, Massimo Offidani, Roberta Della Pepa, Alessandro Gozzetti, Claudio De Magistris

Haematologica· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysis.
Francesca Lazzaroni, Antonio Matera, Alessio Marella, Akihiro Maeda, Giancarlo Castellano, Claudio De Magistris

Blood Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort.
Daniele Cattaneo, Cristina Bucelli, Alfredo Marchetti, Marta Lionetti, Elisa Fermo, Claudio De Magistris

Ann Hematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Chemical Synovectomy in a Patient with Acquired von Willebrand Syndrome with Chronic Synovitis Due to Recurrent Knee Hemarthrosis: A Case Report.
Roberta Gualtierotti, Claudio De Magistris, Eugenia Biguzzi, Jacopo Acquati Lozej, Alessandra Iurlo

Rheumatol Ther· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splenomegaly: Dare to think rare.
Natalia Scaramellini, Giorgio Croci, Claudio De Magistris, Daniele Lello Panzieri, Elena Cassinerio

Am J Hematol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target Therapies for Systemic Mastocytosis: An Update.
Mariarita Sciumè, Claudio De Magistris, Nicole Galli, Eleonora Ferretti, Giulia Milesi

Pharmaceuticals (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural aldehyde extraction and direct preparation of new blue light-emitting imidazo[1,5-a]pyridine fluorophores.
Giorgio Volpi, Claudio Magistris, Claudio Garino

Nat Prod Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Terpyridine and Quaterpyridine Complexes as Sensitizers for Photovoltaic Applications.
Davide Saccone, Claudio Magistris, Nadia Barbero, Pierluigi Quagliotto, Claudia Barolo

Materials (Basel)· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microwave-Assisted Synthesis of Near-Infrared Fluorescent Indole-Based Squaraines.
Nadia Barbero, Claudio Magistris, Jinhyung Park, Davide Saccone, Pierluigi Quagliotto

Org Lett· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, Physicochemical Characterization, and Interaction with DNA of Long-Alkyl-Chain Gemini Pyridinium Surfactants.
Nadia Barbero, Claudio Magistris, Pierluigi Quagliotto, Luca Bonandini, Claudia Barolo

Chempluschem· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conjugation of amino-bioactive glasses with 5-aminofluorescein as probe molecule for the development of pH sensitive stimuli-responsive biomaterials.
Valentina Aina, Gianluca Malavasi, Claudio Magistris, Giuseppina Cerrato, Gianmario Martra

J Mater Sci Mater Med· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining label-free and fluorescence operation of Bloch surface wave optical sensors.
Alberto Sinibaldi, Antonio Fieramosca, Riccardo Rizzo, Aleksei Anopchenko, Norbert Danz, Claudio Magistris

Opt Lett· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New formulation of functionalized bioactive glasses to be used as carriers for the development of pH-stimuli responsive biomaterials for bone diseases.
Valentina Aina, Claudio Magistris, Giuseppina Cerrato, Gianmario Martra, Guido Viscardi

Langmuir· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new practical synthesis of triaryl and trisindolylmethanes under solvent-free reaction conditions.
Margherita Barbero, Silvano Cadamuro, Stefano Dughera, Claudio Magistris, Paolo Venturello

Org Biomol Chem· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An environmentally friendly Mukaiyama aldol reaction catalyzed by a strong Brønsted acid in solvent-free conditions.
Margherita Barbero, Stefano Bazzi, Silvano Cadamuro, Stefano Dughera, Claudio Magistris

Org Biomol Chem· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis